A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET).
Kathryn Maree Field
Other Remuneration - Roche
John Simes
No relevant relationships to disclose
Helen Wheeler
No relevant relationships to disclose
Elizabeth J. Hovey
Consultant or Advisory Role - Roche
Anna K. Nowak
No relevant relationships to disclose
Lawrence Cher
No relevant relationships to disclose
Chris Brown
No relevant relationships to disclose
Ann Livingstone
No relevant relationships to disclose
Kate Sawkins
No relevant relationships to disclose
Mark Rosenthal
Consultant or Advisory Role - Roche